Raymond James Financial Inc Takeda Pharmaceutical CO LTD Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Raymond James Financial Inc holds 143,693 shares of TAK stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
143,693
Previous 82,182
74.85%
Holding current value
$2.02 Million
Previous $1.22 Million
81.75%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TAK
# of Institutions
368Shares Held
73.1MCall Options Held
1.68MPut Options Held
157K-
Capital Research Global Investors Los Angeles, CA13.3MShares$187 Million0.04% of portfolio
-
Morgan Stanley New York, NY7.62MShares$107 Million0.01% of portfolio
-
Goldman Sachs Group Inc New York, NY4.5MShares$63.4 Million0.01% of portfolio
-
Ubs Group Ag4.02MShares$56.7 Million0.01% of portfolio
-
Brandes Investment Partners, LP La Jolla, CA3.71MShares$52.3 Million0.54% of portfolio
About TAKEDA PHARMACEUTICAL CO LTD
- Ticker TAK
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 3,109,050,112
- Market Cap $43.8B
- Description
- Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...